Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Chemomab Therapeutics

Youtube Subscribe

...

Ticker: CMMB

Sector: Biotechnology

Chemomab Therapeutics Ltd stock soars by 961.95% on August 14, 2023: Analysts remain cautious. cm-101 by chemomab therapeutics for systemic sclerosis (scleroderma): likelihood.
...
...
Extended Summary

Chemomab Therapeutics

Chemomab Therapeutics Ltd stock soars by 961.95% on August 14, 2023: Analysts remain cautious. cm-101 by chemomab therapeutics for systemic sclerosis (scleroderma): likelihood of approval. GlobalData tracks drug-specific phase transition and likelihood of. approval scores. Chemomab Therapeutics Ltd. (Nasdaq: CMMB) reports positive data from secondary analyses of its Phase 2a liver fibrosis trial assessing CM-101, its first-in-class CCL24-neutralizing antibody, in patients with non-alcoholic steatohepatitis (NASH) The results were included in a late-breaking poster presentation at the EASL Congress in Vienna.

Related Results

...
February 18, 2024 4:57 (London Time)

Chemomab Therapeutics

Chemomab Therapeutics Ltd. (cmmb) stock price, quote & news - stock analysis. Chemomabs is developing innovative therapeutics for fibro-inflammatory…
Sector: Biotechnology
Ticker: CMMB
Sentiment: 0.6486
MarketCap: 7,089,203.0
High: 0.63 Low: 0.59

Open: 0.59 Close: 0.63 Change: 0.04

Read more →
...
August 20, 2023 10:40 (London Time)

Chemomab Therapeutics

Chemomab Therapeutics Ltd stock soars by 961.95% on August 14, 2023: Analysts remain cautious. cm-101 by chemomab therapeutics for systemic sclerosi…
Sector: Biotechnology
Ticker: CMMB
Sentiment: 0.8555
MarketCap: 12,884,794.0
High: 1.09 Low: 1.05

Open: 1.06 Close: 1.09 Change: 0.03

Read more →
...
October 10, 2023 17:04 (London Time)

Chemomab Therapeutics

Roth MKM analyst Dylan Dupuis initiated coverage with a Buy rating on Chemomab Therapeutics today and set a price target of $7.00. The word on The S…
Sector: Biotechnology
Ticker: CMMB
Sentiment: 0.296
MarketCap: 10,128,157.0
High: 0.9 Low: 0.84

Open: 0.9 Close: 0.87 Change: -0.03

Read more →
Search
Happening Now
Categories